Risk of Cardiovascular Complications in Patients with Persistent Atrial Fibrillation after Dissolution of a Thrombus

E S Mazur1, V V Mazur1, N D Bazhenov1

  • 1Tver State Medical University, Tver.

Kardiologiia
|June 11, 2021
PubMed

Insights

Patients with persistent atrial fibrillation (AF) and resolved left atrial appendage (LAA) thrombi face a significantly higher risk of cardiovascular complications (CVC) compared to those without LAA thrombosis. This includes increased risks of stroke and myocardial infarction.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Thrombosis Research

Background:

  • Persistent atrial fibrillation (AF) is associated with an increased risk of thromboembolic events.
  • Left atrial appendage (LAA) thrombosis is a known complication in AF patients.
  • Understanding the long-term cardiovascular risk after LAA thrombus resolution is crucial for patient management.

Purpose of the Study:

  • To compare the incidence of cardiovascular complications (CVC) in patients with persistent AF following left atrial appendage (LAA) thrombus dissolution versus those without LAA thrombosis.
  • To assess the specific risks of ischemic stroke, myocardial infarction (MI), and other adverse outcomes in these patient groups.

Main Methods:

  • A cohort study comparing 43 patients with resolved LAA thrombosis (main group) to 123 patients without LAA thrombosis (control group), stratified by CHA2DS2‑VASc score.
  • Transesophageal echocardiography was used for LAA thrombosis diagnosis and monitoring.
  • Follow-up duration was approximately 47.3 months, recording all-cause mortality, stroke, bleeding, and MI.

Main Results:

  • The main group experienced significantly higher rates of unfavorable clinical outcomes (39.5% vs. 3.3%, p<0.001).
  • Higher incidence of ischemic stroke (RR, 12.9) and myocardial infarction (MI) (RR, 5.72) was observed in the main group.
  • Stroke incidence rapidly increased in the first year post-thrombus dissolution.

Conclusions:

  • Patients with persistent AF and resolved LAA thrombi have a substantially elevated risk of CVC.
  • The findings underscore the need for vigilant monitoring and potentially intensified anticoagulation strategies in patients with a history of LAA thrombosis.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
86
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
92
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
85
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
285